FDA Approves Risperdal for Kids
The Food and Drug Administration has approved the use of the powerful antipsychotic drug Risperdal for use in preteens and teenagers with schizophrenia or manic depressive illness. Risperdal can be very effective, but it also has some significant side effects.
American Psychiatric Association President Carolyn Robinowitz, M.D., who has been taking care of adults and children with serious psychiatric disorders for nearly 40 years, speaks with Renee Montagne.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.